方法采用免疫放射分析法(IRMA)对88名正常人,69例良性疾病及160例恶性肿瘤患者进行血清CA50水平测定。
Methods The serum CA50 levels were determined by immunoradiometric assay (IRMA) in 88 healthy controls, 69 patients with benign disease and 160 cancer patients.
方法采用免疫放射法(IRMA)对新生儿脐带血tsh水平进行了测定。
Methods The neonatal cord blood TSH levels were measured by immunoradiometric assay (IRMA).
方法:应用免疫放射分析(irma)法测定血清nse含量和应用酶联免疫反应(elisa)法测定血清gst含量。
Methods the serum levels of NSE in cerebral infarction patients were determined with immunoradiometric assay (IRMA), and the serum level of GST were determined by enzyme immuno sandwich assay (ELISA).
方法采用放射免疫分析法(RIA)测定血清中IGF-1水平,免疫放射分析法(IRMA)测定IGFBP-3水平。
Methods The serum IGF-1 level was measured by specific radioimmunoassays(RIA); the serum IGFBP-3 level by immunoradio-assays(IRMA).
方法:采用放射免疫法、免疫放射法、 化学发光法对71例原发性肝癌患者和65例正常人进行肿瘤五项测定;
Methods: A total of subjects were designed, 71 in the primary hepatic cancer (PHC) group, 65 in normal control group.
方法:采用免疫放射度量分析法(irma)法测定74例胃肠道恶性肿瘤患者和35例健康对照者的血清cyfra21 - 1和CA19 - 9含量。
Methods Serum CYFRA21-1 and CA19-9 levels in 74 patients with gastrointestinal malignant tumors and 35 healthy controls were measured by IRMA.
方法:采用免疫放射度量分析法(irma)法测定74例胃肠道恶性肿瘤患者和35例健康对照者的血清cyfra21 - 1和CA19 - 9含量。
Methods Serum CYFRA21-1 and CA19-9 levels in 74 patients with gastrointestinal malignant tumors and 35 healthy controls were measured by IRMA.
应用推荐